Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients

NCT03299829 is registered in ClinicalTrials.gov with Excelsior as lead sponsor.

NCT NCT03299829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03299829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients
Lead sponsor
Excelsior
Phase
Observational
Overall status
Completed
Start date
January 10, 2018
Completion date
December 30, 2019
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

trientine treatment for wilson's disease